                               SEQUENCE LISTING

<110> MAINE MEDICAL CENTER RESEARCH INSTITUTE
 
<120> ENHANCING THE THERAPEUTIC ACTIVITY OF AN IMMUNE CHECKPOINT 
      INHIBITOR

<130> 48420-513001WO

<140> PCT/US2017/018255
<141> 2017-02-17

<150> 62/296,808
<151> 2016-02-18

<160> 21    

<170> PatentIn version 3.5

<210> 1
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Arg Gly Asp Lys Gly Glu 
1               5       


<210> 2
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Lys Gly Asp Arg Gly Asp Ala Pro Gly 
1               5                   


<210> 3
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Gln Gly Pro Arg Gly Asp Lys Gly Glu 
1               5                   


<210> 4
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Gln Gly Pro Ser Gly Ser Pro Gly Glu 
1               5                   


<210> 5
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Cys Lys Gly Asp Arg Gly Asp Ala Pro Gly Cys 
1               5                   10      


<210> 6
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Cys Gln Gly Pro Arg Gly Asp Lys Gly Glu Cys 
1               5                   10      


<210> 7
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Cys Ala Gly Ser Arg Gly Asp Gly Gly Pro Cys 
1               5                   10      


<210> 8
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Cys Gln Gly Ile Arg Gly Asp Lys Gly Glu 
1               5                   10  


<210> 9
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Cys Arg Gly Pro Arg Gly Asp Gln Gly Pro Cys 
1               5                   10      


<210> 10
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Cys Gln Gly Pro Ser Gly Ala Pro Gly Glu Cys 
1               5                   10      


<210> 11
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Arg Gly Asp Ala Pro Gly 
1               5       


<210> 12
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Ala Gly Ser Arg Gly Asp Gly Gly Pro 
1               5                   


<210> 13
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Gln Gly Ile Arg Gly Asp Lys Gly Glu 
1               5                   


<210> 14
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Arg Gly Pro Arg Gly Asp Gln Gly Pro 
1               5                   


<210> 15
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Gln Gly Pro Ser Gly Ala Pro Gly Glu 
1               5                   


<210> 16
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Cys Pro Gly Phe Pro Gly Phe Cys 
1               5               


<210> 17
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Cys Thr Trp Pro Arg His His Thr Thr Asp Ala Leu Leu 
1               5                   10              


<210> 18
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Cys Asn Ser Tyr Ser Tyr Pro Ser Leu Arg Ser Pro 
1               5                   10          


<210> 19
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Cys Lys Gly Asp Arg Gly Asp Ala Gly Pro Cys 
1               5                   10      


<210> 20
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Cys Gln Gly Ile Arg Gly Asp Lys Gly Glu Cys 
1               5                   10      


<210> 21
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Ser Gly Ala Pro Gly Glu 
1               5       


